CVS Bests Wall Street Expectations on Healthy Sales Gain

CVS Q2 Beats Wall Street Expectations

In the second quarter, CVS Health topped analyst estimates although front end comparable sales slipped slightly after a 10% gain in the 2022 period. Company net income was $1.9 billion, or $1.48 per diluted share, versus $3.03 billion, or $2.29 per diluted share, in...